| Financial Year |
March 31 2023 |
| Monetary Funds |
111,522,099.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
67,603,949.57 |
| Accounts Receivable |
1,715,114,254.06 |
| Advances to Suppliers |
8,544,976.61 |
| Other Receivables |
309,768,579.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
99,223,818.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,818,979.91 |
| Other Current Assets |
97,110,895.64 |
| Total Current Assets |
3,090,101,221.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
159,458,020.36 |
| Investment Properties |
148,718,937.18 |
| Fixed Assetes |
257,119,747.41 |
| Under-construction Projects |
506,923.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
272,119,482.49 |
| R&D expenses |
-- |
| Goodwill |
231,936,733.16 |
| Long-Term Deferred and Prepaid Expenses |
88,088,765.22 |
| Deferred Income Tax Assets |
93,387,108.01 |
| Other Non-Current Assets |
144,486,401.62 |
| Sub-Total of Non-Current Assets |
1,445,460,874.15 |
| Total Assets |
4,535,562,095.73 |
| Short-Term Loans |
84,900,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,961,849.92 |
| Accounts Payable |
1,080,829,502.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
48,617,862.27 |
| Taxes Payable |
59,046,536.11 |
| Interest Payable |
-- |
| Dividend Payable |
1,295,100.00 |
| Other payables |
306,990,671.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
222,811,903.98 |
| Other Current Liabilities |
56,694,219.64 |
| Sub-Total of Current Liabilities |
1,887,685,379.96 |
| Long-term Loans |
1,120,163,611.26 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
7,195,936.48 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,566,509.58 |
| Deferred Income Tax Liabilities |
7,249,018.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,190,286,273.30 |
| Total Liabilities |
3,077,971,653.26 |
| Paid-In Capital(Or Share Stock) |
1,147,580,518.00 |
| Capital Surplus |
1,608,617,993.88 |
| Surplus Reserve |
107,169,694.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,381,420,199.32 |
| Minority Stockholder's Interest |
-15,765,324.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,473,355,766.95 |
| Owner's Equity（Stockholder's Equity） |
1,457,590,442.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,535,562,095.73 |
